MRI has had an emerging role in radiotherapy (RT) for a number of years, providing improved visualisation of the tumour and organs at risk (OAR) when compared with CT to improve contouring accuracy. A project team was established in 2016 to procure an MRI scanner designed specifically for RT planning to improve treatment accuracy. MRI […]
Sarah Whittle, Chris Forrest, Dr Richard Speight
Leeds Teaching Hospital NHS Trust
Acute ischaemic stroke (AIS) is the second leading cause of death and the third cause of death and disability worldwide. The estimated global cost of stroke is over $720 billion. In the UK, the incidence of stroke is over 110,000 and the prevalence of stroke is predicted to increase by 120% by 2035. Hyperacute stroke […]
Dr Liam Flynn, Dr Wazim Izzath
Queen Elizabeth University Hospital
MRI, with its unrivalled soft tissue contrast, multiplanar and functional capability, plays an essential role in the imaging and subsequent management of patients with cancer. Among functional imaging techniques, diffusion-weighted imaging (DWI) has significantly impacted oncological imaging over the past two decades. While DWI is primarily the focus of cancer research as a potential biomarker, […]
Erica Scurr
The Royal Marsden NHS Foundation Trust
Rheumatoid arthritis (RA) is a chronic autoimmune and inflammatory condition that damages the lining of synovial joints and subchondral bone marrow. RA progressively causes functional decline, which can lead to permanent pathological deformity and premature mortality due to cardiovascular co-morbidities. RA typically affects the smaller joints of the hands and feet; however, larger joints can […]
Jacob Worsley, Imogen Diggens
University of Suffolk
Cancer of unknown primary (CUP) is an oncological diagnosis encompassing whole body disease sites. The term is used in the context of histologically confirmed epithelial malignancy where comprehensive clinical, radiological and pathological investigations fail to identify the organ of origin. CUP accounts for 1-2% of cancers worldwide with 8,100 new cases per year in the […]
Dr Dimitra Christodoulou, Dr Christian Kelly-Moreland
Guy's and St Thomas' NHS Foundation Trust; The Royal Marsden Hospital NHS Foundation Trust
Imaging is an integral part of diagnosis and treatment. Multiparametric MR prostate imaging is primarily done to evaluate the prostate and to identify targets for biopsy. This helps to reduce sampling errors and improve subsequent correct diagnosis and management of prostate cancers. It is called multiparametric imaging as various sequences such as T2W, T1W, DWI, […]
Dr Kiran Lingaraju, Dr Deepak Pai
Diana, Princess of Wales Hospital
Prostate cancer is the most common cancer in men in 112 countries, and its incidence and mortality will have doubled by 2040. Nearly 50% of newly presenting patients in the UK harbour low and intermediate-favourable-risk localised disease, for which active surveillance (AS) offers non-inferior survival outcomes compared to radical treatment. AS involves repeat testing to […]
Dr Nikita Sushentsev
Emmanuel College, University of Cambridge
A quiet revolution has taken place in MRI over the past two years, with the introduction into routine clinical practice of so-called MR advanced acceleration technology (MR AAT), promising vast reductions in acquisition times and the potential to scan more patients without impacting image quality and without the need to purchase additional MRI systems and […]
Mike Hutton
Newcastle upon Tyne Hospitals NHS Foundation Trust
